Hypertension in the HIV-infected patient

Current Hypertension Reports

Volumn 2, Issue 5, 2000, Pages 478-481

  Aoun, Sola ^a   Ramos, Emilio ^b  

^a RIZK HOSPITAL   (Lebanon)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; ANIMAL; ARTERIOSCLEROSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; VASCULAR DISEASE;

AFRICAN AMERICANS; AIDS-ASSOCIATED NEPHROPATHY; ANIMALS; ARTERIOSCLEROSIS; HIV INFECTIONS; HUMANS; HYPERTENSION; RISK FACTORS; VASCULAR DISEASES;

EID: 0034296316     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-000-0031-1     Document Type: Article

References (41)

1. Galette G, Morrow C: Noninfectious manifestations of human immunodeficiency virus infection. Emerg Med Clin North Am 1995, 13: 105-131.
2. Norbiato G, Galli M, Righini V, Moroni M: The syndrome of acquired glucocorticoid resistance in HIV infection. Clin Endocrinol Metab 1994, 8: 777-787.
3. Norbiato G, Bevilacqua M, Vago T, Clerici M: Glucocorticoid resistance and the immune function in the immunodefi ciency syndrome. Ann NY Acad Sci 1998, 840: 835-847. Suggested mechanisms of modification of the glucocorticoid receptors in HIV patients include altered production of interferon-α and other inflammatory cytokines by HIV-infected cells.
4. Mattana J, Siegal FP, Sandaran RT, Singhal PC: Absence of age-related increase in systolic blood pressure in ambulatory patients with HIV infection. Am J Med Sci 1999, 317: 232-237. A characteristic of the blood pressure profile of patients with HIV infection is the absence of an age-related increase in systolic blood pressure.
5. Nichols WW, O'Rourke MF: McDonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles, fourth edn. Edited by Arnold E. London, Sydney, Auckland: Oxford University Press; 1998.
6. Safar ME: Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens 1989, 7: 769-776.
7. Franklin SS, Gustin W IV, Wong ND, et al.: Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997, 96: 308-315.
8. Valeri A, Neusy AJ: Acute and chronic renal disease in hospitalized patients. Clin Nephrol 1991, 35: 1 1 0-1 1 8.
9. Brady HR, Brenner BM, Lieberthal W: Acute renal failure. In The Kidney, edn 6. Edited by Brenner BM. Philadelphia: WB Saunders; 2000: 1201-1202.
10. Kelleher P, Severn A, Tomson C, et al.: The haemolytic uraemic syndrome in patients with AIDS. Genitourin Med 1996, 72: 172-175.
11. Turner ME, Kher K, Rakusan T, et al.: Atypical hemolytic uremic syndrome in human immunodeficiency virus-1 infected children. Pediatr Nephrol 1997, 11: 161-163.
12. Winston J, Klotman PE: HIV-associated nephropathy. Mt Sinai J Med 1998, 65: 237-232.
13. Frankum BS, Savdie E: HIV and renal disease. Med J Aust 1996, 164: 483.
14. US Renal Data System: USRDS 1995 annual data report. Bethesda, MD: The National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases; 1995.
15. D'Agati V, Suh JL, Carbone L, et al.: Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int 1989, 35: 1358-1370.
16. Wali RK, Drachenberg CI, Papadimitriou JC, et al.: HIV-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998, 352: 783-784.
17. Cantor ES, Kimmel PL, Bosch JP: Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 1991, 51: 125-128.
18. Humphreys MH: Human immunodeficiency virus-associated nephropathy. East is east and west is west? Arch Intern Med 1990, 150: 253-255.
19. Bruggeman LA, Quaggin S, Coffman T, Klotman PE: HIV-associated nephropathy in transgenic mice is due to renal transgene expression. J Am Soc Nephrol 1996, 7: 1851.
20. Poli A, Abramo F, Taccini E, et al.: Renal involvement in feline immunodeficiency virus infection: a clinicopathological study. Nephron 1993, 64: 282-288.
21. Ray PE, Henry D, Xu L, et al.: Infection and injury of human renal tubular epithelial cells by HIV-1 derived from children with HIVAN. J Am Soc Nephrol 1996, 7: 1341.
22. Glassock RJ, Cohen AH, Danovitch G, Parsa KP: HIV infection and the kidney. Ann Intern Med 1990, 112: 35-49.
23. Langs C, Gallo GR, Schacht RG, et al.: Rapid renal failure in AIDS focal glomerulosclerosis. Arch Intern Med 1990, 150: 287-292.
24. Smith MC, Pawar R, Carey JT, et al.: Effect of corticosteroid therapy on human immunodeficiency virus associated nephropathy. Am J Med 1994, 97: 145-151.
25. Cook PP, Appel RG: Prolonged clinical improvement in HIV-associated nephropathy with zidovudine therapy [letter]. J Am Soc Nephrol 1990, 1: 842.
26. Lam M, Park MC: HIV-associated nephropathy: beneficial effect of zidovudine therapy [letter]. N Engl J Med 1990, 323: 1775-1776.
27. Michel C, Dosquet P, Ronoco P, et al.: Nephropathy associated with infection by human immunodeficiency virus: a report on eleven cases including six treated with zidovudine. Nephron 1992, 62: 434-440.
28. Ifudu O, Rao TKS, Tan CC, et al.: Zidovudine is beneficial in human immunodeficiency virus associated nephropathy. Am J Nephrol 1995, 15: 217-221.
29. Burns GC, Matute R, Onyema D, et al.: Response to inhibition of angiotensin converting enzyme in human immunodeficiency virus associated nephropathy: a case report. Am J Kidney Dis 1994, 23: 441-443.
30. Carbone L, D'Agati V, Cheng JT, Appel GB: Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 1989, 87: 389-395.
31. Kimmel PL, Mishkin GJ, Umana WO: Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 1996, 28: 202-208.
32. Chetty R, Batitang S, Nair R: Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol 2000, 31: 374-379.
33. Constans J, Marchand JM, Conri C, et al.: Asymptomatic atherosclerosis in HIV-positive patients: a case-control ultrasound study. Ann Med 1995, 27: 683-685.
34. Paton P, Tabib A, Loire R, Tete R: Coronary artery lesions and human immunodeficiency virus infection. Res Virol 1993, 144: 225-231.
35. Tabib A, Greenland T, Mercier I, et al.: Coronary lesions in young HIV-positive subjects at necropsy [letter]. Lancet 1992, 340: 730.
36. Kestelyn P, Lepage P, Van De Perre P: Perivasculitis of retinal vessels as an important sign in children with AIDS-related complex. Am J Ophthalmol 1985, 100: 614-615.
37. Henry K, Melroe H, Huebsch J, et al.: Severe premature coronary artery disease with protease inhibitors [letter]. Lancet 1998, 351: 1328.
38. Behrens G, Schmidt H, Meyer D, et al.: Vascular complications associated with use of HIV protease inhibitors [letter]. Lancet 1998, 351: 1958.
39. Cattelan A, Trevenzoli M, Naso A, et al.: Severe hypertension and renal atrophy associated with indinavir. Clin Infect Dis 2000, 30: 619-621. A report of a patient with HIV who developed severe hypertension and renal atrophy secondary to indinavir.
40. Hanabusa H, Tagami H, Hataya H: Renal atrophy associated with long-term treatment with indinavir. N Engl J Med 1999, 340: 392-393.
41. Khurana V, De La Fuente M, Bradley TP: Hypertensive crisis secondary to phenylpropanolamine interacting with triple-drug therapy for HIV prophylaxis. Am J Med 1999, 106: 118-119.